| Name | Title | Contact Details |
|---|
One platform that combines case management, records, analytics and more. Custom made for law enforcement, corporate security and beyond.
AmpliFunds grant management software program enables government, healthcare, education and non-profit organizations to efficiently track and manage grant programs from start to finish.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Comprehensive Time & Attendance and Employee Scheduling software, time clocks, mobile solutions, & hundreds of integrations for payroll & ERP/HCM systems.
Interconnecting the world’s IoT data Intelligent automation for productivity, safety, quality and job satisfaction Watch demo now Visualize Merge all of your geospatial and location series data from any source Predict Go from reactive to proactive with...